BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Whole Blood Coagulation Time

Below is an extended Whole Blood Coagulation Time research listing. Click here to return to the Whole Blood Coagulation Time main in depth entry.

Recent Publications on Whole Blood Coagulation Time:

Direct treatment of mouse or human blood with soluble 5'-nucleotidase inhibits platelet aggregation.
OBJECTIVE: Adenosine signaling is known to inhibit platelet aggregation....
Direct Link
26th September, 2008
Department of Anesthesiology and Intensive Care Medicine, University of
Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation.
BACKGROUND: There is considerable variation in the coagulation profile of...
Direct Link
23rd September, 2008
Department of Small Animal Clinical Sciences, Faculty of Life Sciences,
Effects of intercept pathogen inactivation on platelet function as analysed by free oscillation rheometry.
INTRODUCTION: The Intercept Blood System, using InterSol as additive...
Direct Link
20th September, 2008
Department of Clinical Immunology and Transfusion Medicine, Linkoping
Technical report: analysis of citrated blood with thromboelastography: comparison with fresh blood samples. 30th August, 2008
Department of Anesthesia, Toronto General Hospital, University Health
Does hemodilution by the crystalloid priming solution derange the efficacy of anticoagulation during cardiopulmonary bypass?
BACKGROUND AND AIM: Recent studies suggest the development of a...
Direct Link
30th August, 2008
Department of Cardiovascular and Thoracic Surgery, G. B. Pant Hospital,
Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial.
AIMS: To determine the relationship between anticoagulation levels during...
Direct Link
5th August, 2008
Institut de Cardiologie (AP-HP) and INSERM Unit no. 856, Centre
Antithrombogenic properties of a monopivot magnetic suspension centrifugal pump for circulatory assist.
The National Institute of Advanced Industrial Science and Technology...
Direct Link
9th July, 2008
National Institute of Advanced Industrial Science and Technology, Tsukuba,
Preparation and characterization of modified hydroxyapatite particles by heparin.
Heparin-modified hydroxyapatite (HAP-HP) particles were prepared by an in...
Direct Link
28th June, 2008
The Key Laboratory of Beijing City on Preparation and Processing of Novel
[Heparin resistance associated with elevated factor VIII] 25th June, 2008
Department of Anesthesiology, National Hospital Organization, Iwakuni
A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass.
OBJECTIVE: The inadequacy of heparinization during cardiopulmonary bypass...
Direct Link
24th May, 2008
The Royal Infirmary of Edinburgh, Edinburgh, Scotland, United Kingdom.
Systemic antivenom and skin necrosis after green pit viper bites.
INTRODUCTION: As systemic effects of viper venoms can be neutralized by...
Direct Link
16th May, 2008
Department of Medicine, Faculty of Medicine, Chulalongkorn University,
Establishment of a replacement batch for heparin sodium biological reference preparation. 7th May, 2008
EDQM, Council of Europe, 67081 Strasbourg, France.
Effects of shear rate on propagation of blood clotting determined using microfluidics and numerical simulations.
This paper describes microfluidic experiments with human blood plasma and...
Direct Link
30th April, 2008
Department of Chemistry and Institute for Biophysical Dynamics, The
Rotational thrombelastometry for the bedside monitoring of recombinant hirudin.
BACKGROUND: Recombinant hirudin is used as an alternative anticoagulant,...
Direct Link
9th April, 2008
Department of Hemostasis and Transfusion Medicine, University Hospital
A comparison of heparin management strategies in infants undergoing cardiopulmonary bypass.
BACKGROUND: Recent investigations in adult patients have suggested that a...
Direct Link
20th February, 2008
Department of Anesthesiology, Emory University School of Medicine,
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional